Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study

Specific components of lipid profile seem to differently impact on immune activity against cancer and unraveling their prognostic role in patients with solid cancer treated with immune checkpoint inhibitors (ICIs) is needed. We retrospectively collected baseline clinicopathological characteristics i...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2024-03, Vol.29 (3), p.e372-e381
Hauptverfasser:	Pecci, Federica, Cantini, Luca, Cognigni, Valeria, Perrone, Fabiana, Mazzaschi, Giulia, Agostinelli, Veronica, Mentrasti, Giulia, Favari, Elda, Maffezzoli, Michele, Cortellini, Alessio, Rossi, Francesca, Chiariotti, Rebecca, Venanzi, Francesco Maria, Lo Russo, Giuseppe, Galli, Giulia, Proto, Claudia, Ganzinelli, Monica, Tronconi, Francesca, Morgese, Francesca, Campolucci, Carla, Moretti, Marco, Vignini, Arianna, Tiseo, Marcello, Minari, Roberta, Rocchi, Marco Luigi Bruno, Buti, Sebastiano, Berardi, Rossana
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Antilipemic agents Blood lipids Cancer Cancer patients Development and progression Drug therapy Health aspects Immuno-Oncology Immunotherapy Low density lipoproteins Measurement Pharmaceutical industry Prognosis Triglycerides
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!